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Venous Invasion in Patients with Locally Advanced Esophageal
Cancer
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1Department of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands;
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PAST
The presence of tumor cells in blood vessels, particu-
larly extramural venous invasion (EMVI), is an
independent poor prognostic factor in colorectal cancer
(CRC).1,2 The Association of Directors of Anatomic and
Surgical Pathology and the College of American Patholo-
gists define EMVI as the microscopic presence of tumor
cells in venous vessels beyond the muscularis propria.3, 4
The prevalence and significance of EMVI in esophageal
cancer (EC) is still unclear. Most studies focused on dif-
ferentiating venous invasion from lymphatic vascular
invasion (LVI), as expressed in the current TNM classifi-
cation, without assessing where the venous invasion was
located. Problems addressed included the prevalence and
prognostic significance of EMVI in EC resection speci-
mens, and how to overcome difficulties among pathologists
in identifying EMVI by using Elastica van Gieson (EVG)
staining. We investigated archival specimens with patho-
logical T3 or higher from patients operated by surgery
alone, and those after neoadjuvant chemoradiotherapy
(nCRT).5 The key question was whether EMVI can be used
as a predictive factor in the response evaluation of nCRT.
PRESENT
EMVI was present in one-quarter of EC patients after
surgery alone, and in 21.6% of patients after nCRT, as
confirmed by additional EVG staining.5 The prevalence of
EMVI was significantly higher in mid-esophageal and
squamous cell carcinoma. Although significantly higher in
the presence of LVI, EMVI showed no significant corre-
lation with pathological T and N stage. In the nCRT and
surgery-alone groups, EMVI was scored higher in tumors
with lymphatic invasion (75% and 63%, respectively) and
perineural invasion (both 75%). EMVI was shown to be a
strong independent prognostic factor, with significantly
shorter disease-free survival in the surgery-alone group
with respect to EMVI-negative tumors. However, in the
nCRT group, the presence of EMVI was not independently
associated with survival. Based on these results, it seems
necessary to differentiate EMVI from LVI in predicting
prognosis. Therefore, pathologic reports should separately
describe the presence of EMVI. Currently, EMVI can also
be identified on diffuse-weighted (DWI) magnetic reso-
nance imaging (MRI) in CRC patients.6,7
FUTURE
In future, EMVI should be investigated in a larger group
of EC patients undergoing nCRT followed by surgery. Our
results in the nCRT group are probably influenced by case
mix and less power in a relatively small group with a
potential selection bias of non-responders to nCRT.5 The
value of EMVI as an independent predictor of response to
nCRT remains questionable. To determine the impact of
nCRT, we require accurate information about the presence
of EMVI in the pre- and post-CRT setting. Therefore, we
recommend investigation and correlation of EMVI in EC
patients in ongoing or upcoming DWI–MRI studies. For a
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complete pathologic examination, separate reporting of
EMVI in the EC resection specimens should be added.
Moreover, as regression of EMVI after nCRT leads to
vessel fibrosis and can be observed on MRI, it may be used
as a predictive imaging marker in the response evaluation.
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